peptides HPLC + LC-MS

Common GLP-1 blind screen

Blind ID / amount / purity screen covering Semaglutide, Tirzepatide and Retatrutide.

Target
GLP-1 family (blind)
Result format
identified compound, mg/vial, purity %
Min. lyophilizate
1 whole unreconstituted vial
Min. raw / oil
30 mg in sealed glass vial

What’s included

  • Identity confirmation by HPLC + LC-MS
  • Quantitative report: identified compound, mg/vial, purity %
  • Digital COA PDF with QR verification
  • Private confirmation page for labeling & shipping

After checkout you receive a confirmation link for sample labels, report headers, packaging, and tracking — no intake maze during checkout.